Yahoo! Finance 

Yahoo! Finance

a pharmaceutical company developing and commercializing products in the field of dermatology. today announced that Al Altomari. Chief Operating Officer. is scheduled to present to the investment community at the FTN Midwest Health Care Conference.
The conference will be held at the Four Seasons Hotel in New York on June 6-7. 2006. Mr. Altomari is scheduled to present on Wednesday June 7. 2006 at 3:40 p.m. Eastern Daylight Time.
The presentation will be available live via a webcast that can be accessed through Barrier Therapeutics' corporate website at: barriertherapeutics.
Barrier Therapeutics. Inc. is a pharmaceutical company focused on the discovery. development and commercialization of pharmaceutical products in the field of dermatology. The Company currently markets two pharmaceutical products in the United States. and 81.35% white petrolatum) Ointment and Solag'? (mequinol 2.0% and tretinoin 0.01%) Topical Solution. The Company also markets its Solag'? product in Canada. along with VANIQA? for which it is the exclusive distributor in Canada. Barrier's Sebazole(TM) (2% ketoconazole) product candidate. for the treatment of seborrheic dermatitis. is currently under FDA review. Barrier has other product candidates in various stages of clinical development for the treatment of onychomycosis. psoriasis and fungal infections. The Company is headquartered in Princeton. New Jersey and has wholly owned subsidiaries in Geel. Belgium and Ontario. Canada. Web site: barriertherapeutics





acne treatment